Fig. 4From: Migraine treatment: quo vadis? Real-world data study (2015–2022) in SpainTreatment initiation and progression to preventive treatments during the observation period, amongst physician-diagnosed migraine patients who have initiated a treatment for migraine between January 2015 and December 2016 (Cohort B). NSAIDs, Non-steroidal anti-inflammatory drugsBack to article page